JPY 588.0
(0.17%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -11.52 Million | -311.01 Million | 446.61 Million | -470.25 Million | -232 Million |
Net Income | 192.09 Million | 328.62 Million | 212.65 Million | 165.83 Million | 20 Million |
Depreciation & Amortization | 8.82 Million | 9.99 Million | 9.66 Million | 10.75 Million | 16 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -11.9 Million | -595.13 Million | 306.48 Million | -709.9 Million | -271 Million |
Other non-cash items | -84.89 Million | 15.81 Million | -4.61 Million | 70.4 Million | 3 Million |
Investing Cash Flow | 48.24 Million | -3.04 Million | 26.94 Million | -29.4 Million | -6 Million |
Investments in PPE | -815 Thousand | -2.27 Million | -3.45 Million | -102 Thousand | -6 Million |
Acquisitions | - | - | 172 Thousand | - | - |
Investment purchases | -2.2 Million | -1.41 Million | -1.41 Million | -31.88 Million | -1.27 Million |
Sales/Maturities of investments | 50.65 Million | - | 30 Million | - | - |
Other Investing Activities | 502 Thousand | 544 Thousand | 1.52 Million | 2.48 Million | 1.15 Million |
Financing Cash Flow | 190.43 Million | -725.78 Million | 102.56 Million | 713.63 Million | 179 Million |
Debt repayment | -240.7 Million | -675.53 Million | -152.84 Million | -763.96 Million | -21 Million |
Dividends payments | -50.24 Million | -50.25 Million | -50.25 Million | -50.33 Million | -50.26 Million |
Common Stock Repurchased | -25 Thousand | - | -21 Thousand | - | -17 Thousand |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -2000.00 | 36 Million | -2000.00 | -1000.00 | -2000.00 |
Accounts receivables | 825 Million | -550 Million | 273 Million | -314 Million | 142 Million |
Accounts payables | 303.54 Million | -77.07 Million | 77.97 Million | -12.47 Million | -74.02 Million |
Inventory | -1.08 Billion | 52.37 Million | -27.12 Million | -380.43 Million | -322 Million |
Other working capital | -135 Million | -3 Million | -28 Million | 66 Million | -91 Million |
Cash at beginning of period | 993.31 Million | 2.03 Billion | 1.45 Billion | 1.24 Billion | 1.3 Billion |
Cash at end of period | 1.22 Billion | 993.31 Million | 2.03 Billion | 1.45 Billion | -59 Million |
Capital Expenditure | -815 Thousand | -2.27 Million | -3.45 Million | -102 Thousand | -6 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 227.15 Million | -1.03 Billion | 576.11 Million | 213.97 Million | -1.36 Billion |
Free Cash Flow | -12.34 Million | -313.29 Million | 443.15 Million | -470.35 Million | -238 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -14 Million | 192.09 Million | 13 Million | 46 Million | 46 Million | 26 Million |
Depreciation & Amortization | - | 8.82 Million | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -11.9 Million | - | - | - | - |
Other non-cash items | 14 Million | -84.89 Million | -13 Million | -46 Million | -46 Million | -26 Million |
Investing Cash Flow | - | 48.24 Million | - | - | - | - |
Investments in PPE | - | -815 Thousand | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -2.2 Million | - | - | - | - |
Sales/Maturities of investments | - | 50.65 Million | - | - | - | - |
Other Investing Activities | - | 502 Thousand | - | - | - | - |
Financing Cash Flow | - | 190.43 Million | - | - | - | - |
Debt repayment | - | -240.7 Million | - | - | - | - |
Dividends payments | - | -50.24 Million | - | - | - | - |
Common Stock Repurchased | - | -25 Thousand | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -2000.00 | - | - | - | - |
Accounts receivables | - | 825 Million | - | - | - | - |
Accounts payables | - | 303.54 Million | - | - | - | - |
Inventory | - | -1.08 Billion | - | - | - | - |
Other working capital | - | -135 Million | - | - | - | - |
Cash at beginning of period | - | 993.31 Million | - | - | - | - |
Cash at end of period | - | 1.22 Billion | - | - | - | - |
Capital Expenditure | - | -815 Thousand | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 227.15 Million | - | - | - | - |
Free Cash Flow | - | -12.34 Million | - | - | - | - |
6016
GLAXO
S08
034220
CAVA
7048